ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
Abstract Activating mutations of fibroblast growth factor receptor 3 (FGFR3) are common in urothelial carcinoma of the bladder (UC). Silencing or inhibition of mutant FGFR3 in bladder cancer cell lines is associated with decreased malignant potential, confirming its important driver role in UC. Howe...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/7bb60571b5e24f2aa7be8f839790e504 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|